Akyuz, F. Et Al. 2019. Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?. European journal of gastroenterology & hepatology , vol.31 , 777-780.

Akyuz, F., Cavus, B., Iliaz, R., Soyer, O., Ormeci, A., Evirgen, S., ... Onder, S.(2019). Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?. European journal of gastroenterology & hepatology , vol.31, 777-780.

Akyuz, F Et Al. "Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?," European journal of gastroenterology & hepatology , vol.31, 777-780, 2019

Akyuz, F Et Al. "Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?." European journal of gastroenterology & hepatology , vol.31, pp.777-780, 2019

Akyuz, F. Et Al. (2019) . "Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?." European journal of gastroenterology & hepatology , vol.31, pp.777-780.

@article{article, author={F Akyuz Et Al. }, title={Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?}, journal={European journal of gastroenterology & hepatology}, year=2019, pages={777-780} }